Business
First ASX debut of 2021 off to a bang as TruScreen pops – Stockhead
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed. At 11.48 am, TRU shares were trading at 9c…
Link copied toclipboard
Kiwi cervical cancer screening company TruScreen (ASX:TRU) has made a strong debut on the ASX and is now dual-listed.
At 11.48 am, TRU shares were trading at 9c and earlier had reached as high as 9.9c, following a “compliance IPO” in which TruScreen raised about $1.9 million at NZ7c or 6.5c a share.
The company has been listed on the NZX since 2014 and its ASX listing brings back Australian medical technology to Australia.
TruScreen makes a pen-like digital wand that is placed…
-
General21 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General19 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News24 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured
-
Noosa News22 hours agoBrisbane bands unite to help bassist’s cancer fight